Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythromycin effects on gastric motility via VIPUN GMS
NCT04066231Terminated
- Start
- Sep 2019
- Primary completion
- Mar 2020
- Countries
- 1
01
Overview
Open-label trial. Primary endpoints: Gastric Balloon Motility Index baseline and Gastric Balloon Motility Index 120-139. Started Sep 2019; status: terminated.
Beyond the preview
Go deeper on NCT04066231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04066231.